CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 13 of 16

Arthritis & Rheumatology

Briefs 481–520 of 607 CurrentRheuma has covered from this journal, newest publication first

Latest from Arthritis & Rheumatology

All coverage, newest first

  1. Arthritis Rheumatol

    The Clinical Impact of Electronic Patient‐Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta‐analysis

    Meta-analysisRA

  2. Arthritis Rheumatol

    Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial

    Randomized controlled trialLupus & APS

  3. Arthritis Rheumatol

    Identification of Covariates Modulating B‐Cell Repopulation Kinetics in Subjects Receiving Rituximab Treatment

    Cohort studyVasculitis & PMR

  4. Arthritis Rheumatol

    The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

    Diagnostic or prognostic studyLupus & APS

  5. Arthritis Rheumatol

    Risk–Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab

    Cohort studyAcross diseases

  6. Arthritis Rheumatol

    Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti‐CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial

    Randomized controlled trialLupus & APS

  7. Arthritis Rheumatol

    Caspase 1 Enhances Transport and Golgi Organization Protein 1 Expression to Promote Procollagen Export From the Endoplasmic Reticulum in Systemic Sclerosis Contributing to Fibrosis

    Mechanistic studySystemic sclerosis

  8. Arthritis Rheumatol

    Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides During Rituximab Maintenance Therapy

    Randomized controlled trialVasculitis & PMR

  9. Arthritis Rheumatol

    Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis

    Mechanistic studyPediatric

  10. Arthritis Rheumatol

    Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple‐Source Capture–Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

    Cross-sectional studyMyositis

  11. Arthritis Rheumatol

    Differences in JAK Isoform Selectivity Among Different Types of JAK Inhibitors Evaluated for Rheumatic Diseases Through In Vitro Profiling

    Mechanistic studyRA

  12. Arthritis Rheumatol

    Rheumatoid Arthritis–Specific Autoimmunity in the Lung Before and at the Onset of Disease

    Mechanistic studyRA

  13. Arthritis Rheumatol

    Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design

    Guideline or statement

  14. Arthritis Rheumatol

    Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome

    Case-control studySjögren's & overlap

  15. Arthritis Rheumatol

    Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis

    Mechanistic studyRA

  16. Arthritis Rheumatol

    Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin‐4/13 Inhibitor

    Cohort studySpondyloarthritis & PsA

  17. Arthritis Rheumatol

    The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

    Diagnostic or prognostic studyGout & crystals

  18. Arthritis Rheumatol

    Cell Type–Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell‐Intrinsic and Cell‐Extrinsic Circuits

    Mechanistic studySystemic sclerosis

  19. Arthritis Rheumatol

    The Type I Interferon Signature Reflects Multiple Phenotypic and Activity Measures in Dermatomyositis

    Cross-sectional studyMyositis

  20. Arthritis Rheumatol

    The 2022 EULAR / ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome ( HLH / MAS )

    Guideline or statementAutoinflammatory & rare

  21. Arthritis Rheumatol

    Alcohol Consumption and Risk of Total Hip Replacement Due to Hip Osteoarthritis in Women

    Cohort studyOsteoarthritis

  22. Arthritis Rheumatol

    Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis

    Cross-sectional studyPediatric

  23. Arthritis Rheumatol

    Age‐Associated Changes in Knee Osteoarthritis, Pain‐Related Behaviors, and Dorsal Root Ganglia Immunophenotyping of Male and Female Mice

    Mechanistic studyOsteoarthritis

  24. Arthritis Rheumatol

    Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low‐Dose Glucocorticoids and Prevention by Anti‐Osteoporosis Medications

    Cohort studyOsteoporosis

  25. Arthritis Rheumatol

    Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record

    Case-control studyLupus & APS

  26. Arthritis Rheumatol

    Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population‐Based , Prospective Study and Mendelian Randomization Analysis

    Cohort studyGout & crystals

  27. Arthritis Rheumatol

    The Natural Sequence in Which Subclinical Inflamed Joint Tissues Subside or Progress to Rheumatoid Arthritis: A Study of Serial MRIs in the TREAT EARLIER Trial

    Secondary analysisRA

  28. Arthritis Rheumatol

    Amelioration of Fibrotic Remodeling of Human 3‐Dimensional Full‐Thickness Skin by Transglutamase 2 Inhibition

    Mechanistic studySystemic sclerosis

  29. Arthritis Rheumatol

    Comparative Effectiveness of Rituximab‐ Versus Cyclophosphamide‐Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis for the Risk of Kidney Failure and Mortality

    Cohort studyVasculitis & PMR

  30. Arthritis Rheumatol

    V‐Set Immunoglobulin Domain–Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity

    Diagnostic or prognostic studyLupus & APS

  31. Arthritis Rheumatol

    Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis

    Mechanistic studyVasculitis & PMR

  32. Arthritis Rheumatol

    Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial

    Randomized controlled trialSpondyloarthritis & PsA

  33. Arthritis Rheumatol

    Association Between Rheumatoid Arthritis and Osteoporosis in Japanese Populations: A Mendelian Randomization Study

    Research articleRA

  34. Arthritis Rheumatol

    Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

    Randomized controlled trialSystemic sclerosis

  35. Arthritis Rheumatol

    Risk of Venous Thromboembolism With Gout Flares

    Cohort studyGout & crystals

  36. Arthritis Rheumatol

    Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus

    Research articleLupus & APS

  37. Arthritis Rheumatol

    Maternal Anti‐Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune‐Mediated Fetal Heart Disease

    Cohort studyLupus & APS

  38. Arthritis Rheumatol

    Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis

    Cohort studyVasculitis & PMR

  39. Arthritis Rheumatol

    Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy

    Research articlePediatric

  40. Arthritis Rheumatol

    Incidence of Orofacial Manifestations of Juvenile Idiopathic Arthritis From Diagnosis to Adult Care Transition: A Population‐Based Cohort Study

    Cohort studyPediatric

All 607 Briefs in ExploreShowing Briefs 481–520 of 607, newest first